Moderna (CHIX:0QFD) Shareholder Yield % : -0.15% (As of Mar. 2026)


CHIX:0QFD Moderna Inc CHIX:0QFD
20 GF Score
Price €63.59
GF Value €20.82
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Moderna Shareholder Yield %?

Moderna CHIX:0QFD +48.91% 20 Shareholder Yield % is -0.15% as of Mar. 2026. GuruFocus rates CHIX:0QFD with a GF Score™ of 20/100 and a GF Value™ of €20.82 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 1,298 Biotechnology companies, Moderna ranks better than 59.86% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. As of today, Moderna's Shareholder Yield % was -0.15%.


Moderna  (CHIX:0QFd) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Moderna Shareholder Yield % Related Terms


Moderna Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Moderna's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moderna Shareholder Yield % Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shareholder Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 4.01 2.46 0.16 2.03

Moderna Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shareholder Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.76 3.42 5.00 2.03 -0.20

CHIX:0QFD vs RPRX, ROIV, ONC: Shareholder Yield % Comparison

For the Biotechnology subindustry, Moderna's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moderna Shareholder Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moderna's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Moderna's Shareholder Yield % falls into.


CHIX:0QFD
20GF Score
Moderna Inc CHIX:0QFD
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Moderna Shareholder Yield % Calculation

Moderna's Shareholder Yield % for the quarter that ended in Mar. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+-0.25 %+0.58 %
=0.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of -0.15% mean?
Moderna (CHIX:0QFD) has a Shareholder Yield % of -0.15% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Moderna and its competitors. According to the industry distribution chart, Moderna ranks #521 out of 1298 companies in the Biotechnology industry, placing it in the top 40.1%.
Is Moderna's Shareholder Yield % too high?
Moderna's current Shareholder Yield % is -0.15%. Based on the distribution chart, Moderna ranks #521 out of 1298 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Moderna has a GF Score™ of 20/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Moderna's Shareholder Yield % compare to RPRX and ROIV?
According to the Biotechnology industry distribution chart, Moderna ranks #521 out of 1298 companies for Shareholder Yield %. This puts Moderna in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Biotechnology company?
A good Shareholder Yield % depends on the Biotechnology industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Moderna and its competitors. Moderna's current Shareholder Yield % is -0.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Moderna stock overvalued right now?
Based on GuruFocus' analysis, Moderna (CHIX:0QFD) is currently considered Significantly Overvalued. The stock's GF Value™ is €20.82, compared to a current price of €63.59 — trading 205.4% above its estimated fair value. The current Shareholder Yield % is -0.15%. Moderna's overall GF Score™ is 20/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Moderna (CHIX:0QFD), the current Shareholder Yield % is -0.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Moderna (CHIX:0QFD) Overvalued in 2026?

Based on GuruFocus' analysis, Moderna stock appears to be overvalued. The current stock price of €63.59 is trading 205.4% above its estimated GF Value™ of €20.82. GuruFocus considers Moderna to be Significantly Overvalued.

Key valuation signals for CHIX:0QFD:

  • Shareholder Yield %: -0.15%
  • GF Value™: €20.82 vs. price of €63.59 (205.4% above fair value)
  • GF Score™: 20/100 with 7 warning signs

No single metric tells the full story. See the CHIX:0QFD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Moderna Business Description

Address 325 Binney Street, Cambridge, MA, USA, 02142
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
20GF Score

Get the complete analysis for CHIX:0QFD

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€63.59
Price
€20.82
GF Value